Scarica l'app Stockscreener
0.5199
5.47%
-0.0301
Precedente Chiudi:
$0.55
Aprire:
$0.54
Volume 24 ore:
207.22K
Relative Volume:
0.04
Capitalizzazione di mercato:
$6.13M
Reddito:
-
Utile/perdita netta:
$-47.68M
Rapporto P/E:
-0.0208
EPS:
-24.9619
Flusso di cassa netto:
$-23.09M
1 W Prestazione:
-26.55%
1M Prestazione:
+12.87%
6M Prestazione:
-72.35%
1 anno Prestazione:
-94.15%
Intervallo 1D:
$0.51
$0.546
Intervallo di 1 settimana:
$0.51
$0.7385
Portata 52W:
$0.3608
$14.71
BiomX Inc Stock (PHGE) Company Profile
Nome
BiomX Inc
Settore
Industria
Telefono
972 7 23942377
Indirizzo
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.5199 | 6.13M | 0 | -47.68M | -23.09M | -24.96 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-04-15 | Iniziato | Ladenburg Thalmann | Buy |
BiomX Inc Borsa (PHGE) Ultime notizie
BiomX Unveils Strategy as Defense Technology Holding Company - TipRanks
BiomX posts updated presentation outlining defense, DFSL stake, Zorronet platform and go‑forward strategy - TradingView
BiomX (NYSE: PHGE) outlines defense tech portfolio and growth plan - Stock Titan
BiomX Provides Update on Defense Technology Portfolio and Growth Strategy - GlobeNewswire
Biomx Inc (PHGE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biomx Inc (PHGE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biomx Inc (PHGE) Institutional Confidence - TradingKey
Biomx Inc (PHGE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomx Inc (PHGE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biomx Inc (PHGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biomx Inc (PHGE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomx Inc (PHGE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomx Inc (PHGE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BiomX Inc. (PHGE) Holds Steady Near Support as Small Gain Suggests Cautious RecoveryIntraday Profile - newsline.com
Deerfield group now holds 4.70% of BiomX (PHGE) stock, below 5% - Stock Titan
PHGE (NYSE American: PHGE) expands ATM capacity to $5.06M; prior $1.38M sold - Stock Titan
BiomX Inc. (PHGE) Q4 2025 Earnings: EPS Misses Estimates as Company Advances PipelineEarnings Miss Alert - newsline.com
Number of shareholders of BiomX Inc. – AMEX:PHGE - TradingView
PHGE Q4 2025 Earnings: Significant EPS Miss Amid Clinical-Stage LossesOne-Time Gain Impact - newsline.com
BiomX Wins NYSE Compliance Plan Extension to 2027 - The Globe and Mail
PHGE - Finviz
BiomX Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
BiomX (PHGE) wins NYSE American plan period after equity deficit warning - Stock Titan
BiomX Announces NYSE American Acceptance of Plan to Regain Compliance - The Manila Times
BiomX gets more time to fix NYSE listing compliance issues - Stock Titan
BiomX (PHGE) details Zorronet and Dr. Frucht Systems acquisition financials - Stock Titan
PHGE Should I Buy - Intellectia AI
BiomX Inc. Publishes Review on the Future of AI in Security Industry by Zorronet CEO Idan Wasserman - Quiver Quantitative
BiomX: Zorronet’s AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events - The Manila Times
Why stadium security AI must learn crowd behavior, not just spot threats - Stock Titan
BiomX Company Profile & Introduction - Moomoo
Large new equity pool and board election at BiomX (PHGE) 2026 meeting - Stock Titan
· Analyst Forecast - MLQ.ai
PHGE Q4 2025 Earnings: Wider-than-Expected Loss Sends Shares LowerEarnings Weakness Phase - newsline.com
BiomX Inc. Enters Line of Credit Agreement and Issues 12% Convertible Promissory Note – SEC 8-K Filing June 2026 - Minichart
BiomX subsidiary launches mobile command app for operators - Investing.com
BiomX Issues Restricted Shares Under Mandragola Credit Facility - TipRanks
BiomX (NYSE: PHGE) converts debt to shares and grants 2M-share warrant - Stock Titan
BiomX Inc. Appoints Former Elbit Systems Chief Scientist Gabby Sarusi to Board of Directors - geneonline.com
BiomX announces CEO and board changes, appoints Michael Oster as chief executive - Investing.com
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit - The Manila Times
BiomX Inc. Appoints Prof. Gabby Sarusi as Strategic Advisor to Enhance Defense and Security Capabilities - Moomoo
Ex-Elbit defense scientist joins BiomX push into threat-detection tech - Stock Titan
BiomX expands Zorronet's AI C5ISR suite for secure on-premise defense and critical infrastructure use. - Pluang
Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence - The Manila Times
AI security system moves on-site: no public cloud for hardened facilities - Stock Titan
PHGE Q4 2025 Earnings: EPS Miss of -$8.17 Amid Continued Clinical DevelopmentMid-Term Outlook - newsline.com
BiomX Appoints Roy Rousso as Chief Business Officer - The Globe and Mail
Deerfield funds report 8.09% BiomX (PHGE) ownership after warrant and preferred conversions - Stock Titan
BiomX Inc. Appoints Roy Rousso as Chief Business Officer Effective July 1, 2026 – Details of Consulting Agreement - Minichart
BiomX appoints Roy Rousso as Chief Business Officer - TradingView
BiomX Inc Azioni (PHGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):